Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma. J of Skin 2020, 4 (5), s64. https://doi.org/10.25251/skin.4.supp.63.